Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer

Chinese Medical Journal

Volumn 110, Issue 2, 1997, Pages 142-144

  Qian, Ming ^a   Feng, Youji ^a   Xu, Liangzhong ^a   Zheng, Songguo ^a   Zhou, Xianrong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; TRANSCRIPTION FACTOR;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; CYSTADENOCARCINOMA; ENDOMETRIOID CARCINOMA; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LYMPH NODE METASTASIS; OVARY TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0031061560     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Goldfarb RH, Brunson KW. Antimetastatic therapy. In: Devita VT, Hellman S, Rosenberg Sa, eds. Biologic therapy of cancer. 2nd ed. Philadelphia: Lippincott JB Company, 1995: 853-61.
2. Steeg PS, Bevilacqua G, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potenual. J Natl Cancer Inst 1988; 80:200.
3. Cohn KH, Wang FS, Fidelina DL, et al. Association of nm23-Hlallelic deletions with distant metastases in colorectal carcinoma. Lancer 1991; 338:722.
4. Nakamori S, Ishikama O, Ohhigashi H, et al. Expres- sion of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 1993; 11:151.
5. Sawan A, Lascu I, Veron M, et al. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study. J Pathol 1994; 172:27.
6. Tokunaga YJ, Urano T, Furukawa K, et al. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequence of lymph-node metastasis of human breast cancer. Int J Cancer 1993; 55:60.
7. Campo E, Minquel R, Jares P, et al. Prognostic significance of the loss of heterozygosity of nm23-H1 and p53 genes in human colorectal carcinomas. Cancer 1994; 73:2913.
8. Jacobs IJ, Smith SA, Wiseman RW, et al. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Cancer Res 1993; 53:1218.
9. Pickel H, Lahousen M, Girardi F, et al. Intraperitoneal and retroperitoneal spread of ovarian cancer. In: Sharp F, Mason WP, Leake RE, eds. Ovarian cancer. London: Chapman and Hall Ltd, 1990:171-78.
10. Mandai M, Komishi I, Koshiyama, et al. Expression of metastasis-related nm23-H1 and nm23-H2 gene in ovarian carcinomas: correlation with clinicopathology, EGFR, C-erb B2 and C-erb B3 genes, and sex steroid receptor expression. Cancer Res 1994; 54:1825.
11. Dire F, Fontanelli R, Raspagliesi F, et a . The value of lymphadenectomy in the management of ovarian cancer. In: Sharp F, Mason WP, Leake RE, eds. Ovarian cancer. London: Chapman and Hall Ltd, 1990:437-42.